CDSCO
- Hyderabad
Hyderabad: Biphore, Zenara get CDSCO approval for neuro disorder drug
Hyderabad: Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control Organisation (CDSCO) for manufacturing and marketing of Cannabidiol active ingredient in India. Its subsidiary,…
- India
Over 3 percent of 84,874 drug samples tested in 2020-21 were found substandard: Govt
New Delhi: More than three percent of the 84,874 drug samples tested in 2020-21 were declared not of standard quality and 263 of them were found to be spurious and adulterated, Minister…
- India
CDSCO approved recombinant nasal Covid vaccine on Sep 5: Govt in Rajya Sabha
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) approved the recombinant nasal COVID-19 vaccine on September 5 this year for those aged 18 years and above, Minister of State for Health…
- India
CDSCO launches probe after WHO issues alert on four Indian cough syrups
New Delhi: After World Health Organization (WHO) on Wednesday issued an alert on four India-made cough and cold syrups ‘potentially linked with acute kidney injuries and 66 deaths among children in Gambia’,…
- Health
BE gets approval to manufacture pediatric vaccine for S. pneumonia
Hyderabad: Vaccine manufacturer Biological E. Limited (BE) announced on Thursday that the Subject Expert Committee of Central Drugs Standard Control Organization (CDSCO) has approved the Phase 3 infants clinical trial data and…
- India
India’s precautionary COVID-19 doses not approved by CDSCO
The precautionary doses of COVID-19 vaccines rolled out by PM Modi on January 10, 2022, were not approved by the Central Drug Standards Control Organisation (CDSCO). The nodal drug agency of the…
- India
Sputnik’s single-dose vax gets DCGI nod for Phase-III trials in India
New Delhi: The Drugs controller general of India (DCGI) has granted permission for the conducting of the Phase III bridging trials of Sputnik light on the Indian population. The Sputnik Light is a…
- Hyderabad
Covaxin’s Phase 3 trials results likely next month
Hyderabad: The results of third phase trials of India’s first indigenously developed COVID-19 vaccine Covaxin are expected to be released next month.Covaxin manufacturer Bharat Biotech said its service provider, IQVIA, has started…
- India
Expert panel recommends granting approval to Russia’s COVID vaccine Sputnik V in India
New Delhi: An expert panel of India’s central drug authority has recommended granting approval to the Russian COVID-19 vaccine Sputnik V for emergency use in the country with certain conditions, sources said.…
- Crime in Hyderabad
Deputy Drugs Controller suspended for corruption
New Delhi:The Union Health Ministry has suspended Deputy Drugs Controller Naresh Sharma, posted at the Central Drugs Standard Control Organisation (CDSCO), following his arrest by the CBI on charges of corruption, an…
